The new hybrid cardiac catheterization lab is a 730-square-foot suite equipped with advanced imaging equipment to perform complex minimally invasive procedures with greater precision, such as Transcatheter Aortic Valve Repair (TAVR),...
The new hybrid cardiac catheterization lab is a 730-square-foot suite equipped with advanced imaging equipment to perform complex minimally invasive procedures with greater precision, such as Transcatheter Aortic Valve Repair (TAVR),...
Researchers followed more than 6,000 adults for 10 years and found that, for the overall study population, adding a coronary artery calcium score provided only a small improvement over PREVENT, the American Heart Association's primary...
Researchers followed more than 6,000 adults for 10 years and found that, for the overall study population, adding a coronary artery calcium score provided only a small improvement over PREVENT, the American Heart Association's primary...
The score could eventually help clinicians assess risk in real time during emergency angiography or it could help identify patients who need closer monitoring after a blocked artery is reopened. The score may also help doctors decide which...
The score could eventually help clinicians assess risk in real time during emergency angiography or it could help identify patients who need closer monitoring after a blocked artery is reopened. The score may also help doctors decide which...
WASHINGTON—The American College of Cardiology (ACC), The Society of Thoracic Surgeons (STS), and the Society for Cardiovascular Angiography and Interventions (SCAI), released the following joint statement on the transcatheter aortic valve...
WASHINGTON—The American College of Cardiology (ACC), The Society of Thoracic Surgeons (STS), and the Society for Cardiovascular Angiography and Interventions (SCAI), released the following joint statement on the transcatheter aortic valve...
Edwards Lifesciences issued the following statement in response to the national coverage determination (NCD) for transcatheter aortic valve replacement (TAVR) released by the Centers for Medicare & Medicaid Services (CMS).
Edwards Lifesciences issued the following statement in response to the national coverage determination (NCD) for transcatheter aortic valve replacement (TAVR) released by the Centers for Medicare & Medicaid Services (CMS).
The new tool, called ECG-CLIP, was trained using over 1.7 million ECGs collected from more than 540,000 people and paired with clinicians’ notes, embedding the tool with knowledge that may make it more adaptable for different disease...
The new tool, called ECG-CLIP, was trained using over 1.7 million ECGs collected from more than 540,000 people and paired with clinicians’ notes, embedding the tool with knowledge that may make it more adaptable for different disease...
Although lower Lp(a) levels were observed with pelacarsen, the findings did not demonstrate that this translated into reduced cardiovascular risk in the overall study population.
Although lower Lp(a) levels were observed with pelacarsen, the findings did not demonstrate that this translated into reduced cardiovascular risk in the overall study population.
CMS estimates that aggregate Medicare payments for cardiovascular procedures performed in ASCs would increase 5% in 2027, compared with a 2% increase across ASC services overall, reflecting in part the relatively high proportion of...
CMS estimates that aggregate Medicare payments for cardiovascular procedures performed in ASCs would increase 5% in 2027, compared with a 2% increase across ASC services overall, reflecting in part the relatively high proportion of...
Pi-Cardia's ShortCut™ device is the first FDA-cleared leaflet modification technology designed to enable valve-in-valve TAVR procedures in patients at risk of coronary obstruction.
Pi-Cardia's ShortCut™ device is the first FDA-cleared leaflet modification technology designed to enable valve-in-valve TAVR procedures in patients at risk of coronary obstruction.
SAN CLEMENTE, CA – September 1, 2026 – Reflow Medical, Inc. announced that the Centers for Medicare & Medicaid Services (CMS) has granted the Spur Peripheral Retrievable Stent System a New Technology Add-on Payment (NTAP), providing...
SAN CLEMENTE, CA – September 1, 2026 – Reflow Medical, Inc. announced that the Centers for Medicare & Medicaid Services (CMS) has granted the Spur Peripheral Retrievable Stent System a New Technology Add-on Payment (NTAP), providing...
